The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Open accessAbstract
Cyclic guanosine monophosphate (cGMP) is a second messenger molecule that transduces nitric-oxide- and natriuretic-peptide-coupled signalling, stimulating phosphorylation changes by protein kinase G. Enhancing cGMP synthesis or blocking its degradation by phosphodiesterase type 5A (PDE5A) protects against cardiovascular disease. However, cGMP stimulation alone is limited by counter-adaptions including PDE upregulation. Furthermore, although PDE5A regulates nitric-oxide-generated cGMP, nitric oxide signalling is often depressed by heart disease. PDEs controlling natriuretic-peptide-coupled cGMP remain uncertain. Here we show that cGMP-selective PDE9A (refs 7, 8) is expressed in the mammalian heart, including humans, and is upregulated by hypertrophy and cardiac failure. PDE9A regulates natriuretic-peptide- rather than nitric-oxide-stimulated cGMP in heart myocytes and muscle, and its genetic or selective pharmacological inhibition protects against pathological responses to neurohormones, and sustained pressure-overload stress. PDE9A inhibition reverses pre-established heart disease independent of nitric oxide synthase (NOS) activity, whereas PDE5A inhibition requires active NOS. Transcription factor activation and phosphoproteome analyses of myocytes with each PDE selectively inhibited reveals substantial differential targeting, with phosphorylation changes from PDE5A inhibition being more sensitive to NOS activation. Thus, unlike PDE5A, PDE9A can regulate cGMP signalling independent of the nitric oxide pathway, and its role in stress-induced heart disease suggests potential as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many technological developments have been prominent, including phospho-PTM analysis to identify PDE5A targets in heart failure therapy118”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [118]
In the citing paper
“Now, identification of proteoforms (e.g., genetic variations, alternatively spliced products, phosphorylation118, glycosylation119, oxidative120 and other PTMs121) allow CVD sub-classification.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Conti, M., & Beavo, J. A. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,219
Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G. D., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,164
Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart
Zhou, B., Ma, Q., Rajagopal, S., Wu, S. M., Domian, I., Rivera-Feliciano, J., Jiang, D., von Gise, A., Ikeda, S., Chien, K. R., et al. (2008) · Nature · doi:10.1038/nature07060 · Cited by 1,019
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D. F., Ren, S. V., Rodríguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 902
Self-citationAdvances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J. H., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 824
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
van Heerebeek, L., Hamdani, N., Falcão‐Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, G. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 545
Self-citationHeart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies
Sharma, K., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.302922 · Cited by 508
Self-citationOka, T., Maillet, M., Watt, A. J., Schwartz, R. J., Aronow, B. J., Duncan, S. A., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000215985.18538.c4 · Cited by 424
A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In Vivo
Davis, J., Burr, A. R., Davis, G. F., Birnbaumer, L., & Molkentin, J. D. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.017 · Cited by 362
Cited by
Sorted by citations
Items 301–357 of 357
Modulation of Cardiac Titin Stiffness in Physiological and Pathophysiological States
Slater, R. E. (2016) · UA Campus Repository (The University of Arizona)
Signalling Microdomains: The Beta-3 Adrenergic Receptor/NOS Signalosome
Hammond, J., & Balligand, J. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-54579-0_11
Computational Modeling of Cyclic Nucleotide Signaling Mechanisms in Cardiac Myocytes
Zhao, C. Y. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-54579-0_10
Cyclic GMP/Protein Kinase Localized Signaling and Disease Implications
Lin, B. L., Kass, D. A., & Lee, D. I. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-54579-0_13
Self-citationThe Phosphodiesterase-5 Inhibitors and Prostate Cancer – What We Rely Know About It?
Simić, D., Spasic, A., Jovanovic, M., Marić, P., Milosevic, R., & Srejovic, I. M. (2019) · Serbian Journal of Experimental and Clinical Research · doi:10.1515/sjecr-2017-0073
The effect of lidocaine on gene function and the possibility of side effects
Khodkova, Y., & Yanchenko, V. (2020) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2020.2.58
Molecular Basis of Heart Failure
Diwan, A., & Hill, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00001-6
Molecular and functional compartmentation of cGMP in the heart
Calamera, G. (2020) · NORA - Norwegian Open Research Archives
Lugnier, C., Meyer, A., Charloux, A., Andrès, E., Gény, B., & Talha, S. (2021)
Jiang, H., Zheng, Y., Ni, J., & Xu, Y. (2021) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2021.2539
de Oliveira, T. R., Mello, C. D. L., Lima, A. R. B. S. O., & Yochida, B. M. R. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006728
ASSISTÊNCIA A PESSOAS PORTADORAS DE LESÃO POR PRESSÃO
Barbosa, A. B., Oliva, L. D. C., Lassala, J. N., da Silva, P. B., da Silva, G. N., Almeida, R. O., de Carvalho, A. P. F., Soares, A. D. J., de Souza, R. R., & de Oliveira, A. C. B. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006660
Gonçalves, B. F. P., de Oliveira, J. M. M., & Fernandes, A. H. F. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006673
Doença articular degenerativa, artrose ou osteoartrose: relato de caso
Guimarães, J. V. P. D. A., Farias, L. D. C., Mocelin, A. T., Neto, D. M., & Martiniano, L. C. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006639
Repercussões do uso abusivo de anabolizantes na função sexual masculina.
Filho, A. E. D. A. R., Maciel, V. C., de Melo, L. P. M., de Moraes, M. S. F., de Sousa, G. G. K., da Costa, J. V., Crispim, J. V. D. A., Silva, V. D., Lopes, A. L. C., & Amaral, M. V. G. C. D. C. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006776
USO INADEQUADO DE TERAPIA HORMONAL POR MULHERES NO CLIMATÉRIO
Vicente, N. A. M. P., BRAZ, F. R., NETO, L. B., QUIRINO, N. S., & SÁ, T. C. D. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006770
Desafios encontrados na minimização dos erros de medicação em ambientes hospitalares
França, M. S., Medeiros, G. D. O., & Mendes, E. I. R. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006724
PANORAMA CIENTÍFICO DA CATARATA CONGÊNITA: UMA REVISÃO DE LITERATURA
Sylvestre, B. N. F. D. A. Z., Dantas, T. P., Ribeiro, J. C. M. L., & Ferreira, J. D. L. M. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006747
Weber, D. A., Barros, C. V., Piovezan, M. F. B., Giolo, M. S. D. S., & Bumlai, P. H. D. A. G. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006659
PERFIL DA RESPOSTA IMUNOLÓGICA NA COVID-19
Dellalibera-Joviliano, R., Kakunaka, C. E., Pedra, Y. F., & Dellalibera, E. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006752
de Azevedo, N. V., & Paranhos, M. G. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006721
A PARTICIPAÇÃO DO MECANISMO INFLAMATÓRIO DO ÓXIDO NÍTRICO NAS LESÕES DO TECIDO CARDÍACO
Estabile, B. L., Faria, V. A. C., & Dellalibera-Joviliano, R. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/221006757
On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implicationsPreprint
Petraina, A., Elbatreek, M. H., Neullens, C. T., Saridaki, T., Dao, V. T.-V., Casas, A. I., & Schmidt, H. H. H. W. (2023) · doi:10.14293/s2199-1006.1.sor-.ppw9ffl.v1
Fibrillation and Flutter of the Heart, Pathological Aspects of the Mechanism
Газимагомедович, Х. Р., & Рашитбековна, М. Э. (2022) · Mathews Journal of Cardiology · doi:10.30654/mjc.10023
A methane–cGMP module positively influences adventitious rooting
Kong, L., Wang, Y., Li, M., Cai, C., Li, L., Wang, R., & Shen, W. (2023) · Plant Cell Reports · doi:10.1007/s00299-023-03019-4
Agrawal, V., Kropski, J. A., Gokey, J. J., Kobeck, E., Murphy, M., Murray, K. T., Fortune, N. L., Moore, C. S., Meoli, D. F., Monahan, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.18.541302
Combination of QTL and GWAS to uncover the role of phosphodiesterases in ischemic heart diseasePreprint
Xiao, J., Gao, Z., Wei, H., Wei, Y., Qiu, Z., & Huang, W. (2023) · medRxiv · doi:10.1101/2023.09.24.23296052
Innovative Dual Targeting of the Phosphodiesterase Family and Cyclic GMP Pathway in Heart Failure
Burnett, J. C. J. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.10.008
Les phosphodiestérases des nucléotides cycliques
Barthou, A., Kamel, R., Leroy, J., Vandecasteele, G., & Fischmeister, R. (2024) · médecine/sciences · doi:10.1051/medsci/2024083
Spratt, M. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.250821
Beta Testing New Roles of Cyclic Guanosine Monophosphate in Cardiac Myocyte Contractility
Blanton, R. M. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.05.012
Tatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867.2
Tatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867.3
DNA methylation and gene expression trajectories of human postprandial metabolismPreprint
Costeira, R., Daimiel, L., Gehrmann, T., Bogaards, F. A., Villicaña, S., Sinke, L., Raza, Y. N., Tomlinson, M., Christiansen, C., Heijmans, B. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.29.626085
Bai, Z., Li, P., Gao, X., Zu, G., Jiang, A., Wu, K., Mechawar, N., Turecki, G., Lehnert, K., Snell, R. G., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03202-5
Cao, X., Zhang, Y., Tripp, A., Steinhauer, R., Liu, P., Aronovitz, M. J., Martin, G., Wang, B., Alissa, A., Aljuaid, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.12.638003
Wnt5a-mediated Adipo-Cardiac Interorgan Communication in HFpEFPreprint
Fatima, A., Abusharkh, F., Zanetta, Z., Gardner, S., Shi, F., Kobeck, E., Fortune, N. L., Subati, T., Bachmann, K. N., Brown, J. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.29.685456
Susmi, T. F., Rahman, A., Khan, M. M. R., Yasmin, F., Islam, M. S., Nasif, O., Alharbi, S. A., Batiha, G. E.-S., & Hossain, M. U. (2021) · Figshare · doi:10.6084/m9.figshare.14633625
Mango Fruit Contribution to Human Nutrition and Health
Celis, M. E. M., & Yahia, E. M. (2026) · Botany, production and uses. · doi:10.1079/9781800622647.0024
Bheeman, J., Dhanabalan, A. K., Nagaraj, G., Elangovan, T., Moorthy, N. D., Dhanusu, S., & Vellaichamy, E. (2026) · Peptides · doi:10.1016/j.peptides.2026.171487
Le canal calcique Orai1 : nouvel acteur impliqué dans la physiopathologie cardiaque
Bartoli, F. (2018) · theses.fr (ABES) · doi:10.70675/ae1f33b5z4901z4c0ez8c35z0007766ad690
Thérapie génique de l'insuffisance cardiaque par les phosphodiestérases
Bourcier, A. (2019) · theses.fr (ABES) · doi:10.70675/19ee12d6z21e8z440fza3cfz9b22674b5d02
Titin Modification as a Potential Treatment for Chronic Heart Failure with Preserved Eject Fraction
Vakhrushev, Y. A., Bagandov, A. A., Lyasnikova, E. A., & Kostareva, A. A. (2026) · Translational Medicine · doi:10.18705/2311-4495-2026-13-31-41
Kinoshita, H., 木村敬太, Masada, K., Shimonaga, T., & Sugino, H. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2026.101953
Yuan, W., Zhou, B., & Yu, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1954549
Packer, M., Butler, J., Zannad, F., Vaduganathan, M., & Borlaug, B. A. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.09.029
BindingDB (2024) · UC San Diego · doi:10.7270/q2nv9pfn
BindingDB (2023) · UC San Diego · doi:10.7270/q2j96b8p
Metadata
- Authors
- Lee, D. I., Zhu, G., Sasaki, T., Cho, G.-S., Hamdani, N., Holewinski, R., Jo, S.-H., Danner, T., Zhang, M., Rainer, P. P., Bedja, D., Kirk, J. A., Ranek, M. J., Dostmann, W. R., Kwon, C., Margulies, K. B., Van Eyk, J. E., Paulus, W. J., Takimoto, E., & Kass, D. A.
- Affiliations
- Johns Hopkins University (US)
- Tanabe Pharma Corporation (Japan) (JP)
- Amsterdam Cardiovascular Sciences (NL)
- Cedars-Sinai Medical Center (US)
- Kangwon National University (KR)
- University of Vermont (US)
- University of Pennsylvania (US)
- Corresponding author
- Kass, David A.
- ORCID
- Venue
- Nature
- Published
- 2015-03
- Volume
- 519
- Issue
- 7544
- Pages
- 472-476
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376609
- OpenAlex
- W2020159180
- Cited by
- 353
- References
- 30
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 36 · 2023: 22 · 2022: 41 · 2021: 44 · 2020: 34 · 2019: 33 · 2018: 41 · 2017: 27 · 2016: 37 · 2015: 14
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- American Heart Association
- Pfizer
- University of Pennsylvania
- University of Connecticut
- Johns Hopkins University
- European Commission (261409)
- Fondation Leducq (HL-093432)
- Österreichischen Akademie der Wissenschaften
- National Institutes of Health (HHSN268201000032C, n01hv28180-13-0-0, HL-07227, HL089847)
- National Heart, Lung, and Blood Institute (NHLBI-HV-10-05, HL089297, R01HL093432, HL-07227, N01 HV028180, HHS-N268201000032C, R01HL119012, HL105993, HL093432, HL-119012, HL-68891, HL089847, P01HL107153, R01HL089297, R01HL089847, R01HL111198, R01HL105993, T32HL007227, R01HL068891)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- PDE9A, PDE5A, cGMP signaling, cardiac hypertrophy, heart failure, pressure overload, cardiomyocytes, protein kinase G, heart disease treatment, nitric oxide synthase, neurohormones, cardiomyopathy
- MeSH terms
- Animals, Aortic Valve Stenosis, Cyclic GMP, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Myocardium, Nitric Oxide, Phosphodiesterase Inhibitors, Pressure, Stress, Physiological, 3',5'-Cyclic-AMP Phosphodiesterases, Signal Transduction, Up-Regulation, Nitric Oxide Synthase, Muscle Cells, Natriuretic Peptides, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
